APOLLOMICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2117 USD | -3.77% |
|
+10.55% | -78.06% |
| 06-04 | Apollomics Announces Vebreltinib Data At the 2024 American Society of Clinical Oncology Annual Meeting | CI |
| 05-08 | Apollomics, Inc. Appoints Robert Lin to the Board of Directors | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.2524 | 0.3965 | 0.9890 |
| Spread/Res. | -16.13% | -46.61% | -78.59% |
| Spread/Supp. | +10.55% | +10.55% | +5.32% |
| Support | 0.1915 | 0.1915 | 0.2010 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- APLM Stock
- Charts Apollomics, Inc.
